Potential Alternative Drug Therapies For Neuroblastoma Revealed By New Genomic Screening
5/27/2013
Nearly two-thirds of patients with high-risk neuroblastoma - a common tumor that forms in the nerve cells of children - cannot be cured using tumor-killing cancer drugs...
Breast Cancer Advance That Turns Previous Thinking On Its Head
5/27/2013
Scientists at the University of East Anglia have made an advance in breast cancer research which shows how some enzymes released by cancerous cells could have a protective function...
Economic Incentives Increase Blood Donations Without Negative Consequences
5/27/2013
Canada and other countries should reassess guidelines that prohibit offering economic incentives such as gift cards to potential blood donors, says a study from the University of Toronto Mississauga (UTM)...
As Proof Of Principle, Technique Finds Antibody That Mimics Key Hormone For Blood Clotting
5/27/2013
Scientists at The Scripps Research Institute (TSRI) have devised a powerful new technique for finding antibodies that have a desired biological effect. Antibodies, which can bind to billions of distinct targets, are already used in many of the world's best-selling medicines, diagnostics and laboratory reagents...
At Initial Screening Exam, Twice As Many Lung Cancers Detected By CT Compared To X-ray
5/27/2013
National Lung Screening Trial (NLST) investigators also conclude that the 20 percent reduction in lung cancer mortality with low-dose computed tomography (LDCT) versus chest X-ray (CXR) screening previously reported in the NLST primary paper is achievable at experienced screening centers in the United States...
Aggressive Prostate Cancer Tumors Share The Same Genetic Origins
5/27/2013
Using a new form of genomic analysis, researchers at Mayo Clinic have identified that some of the more aggressive prostate cancer tumors share the same genetic origins, lending more insight into the development of prostate cancer. The finding, published in the journal Cancer Research, could significantly help predict prostate cancer progression...
Two Gene Mutations Responsible For Infantile Myofibromatosis Identified
5/27/2013
Researchers at Mount Sinai have identified two mutations responsible for the development of infantile myofibromatosis (IM) - a tumor disorder of the skin, bone, and tissue. The finding, published in The American Journal of Human Genetics, is crucial for the development of treatment options for the disease, providing new therapeutic drug targets...
Identifying Abnormally Activated Genes To Predict Cancer Virulence
5/27/2013
Scientists have found a new way of tackling cancer and predicting the virulence of tumors, an article published in Science Translational Medicine (May 22nd 2013 issue) reported. The researchers, from the Institut Albert Bonniot de Grenoble, CNRS, Inserm and Université Joseph Fourier, all in France, worked together with doctors and anatomopathologists from the CHU de Grenoble...
When Patients Develop Bloodstream Infections, Hospitals Profit
5/27/2013
Johns Hopkins researchers report that hospitals may be reaping enormous income for patients whose hospital stays are complicated by preventable bloodstream infections contracted in their intensive care units...
Potential New Inhaled Treatment For Lung Cancer
5/26/2013
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage done to other organs while significantly improving the treatment of lung tumors...